Volume 18, Number 6—June 2012
Letter
Pneumococcal Serotype–specific Unresponsiveness in Vaccinated Child with Cochlear Implant
Table
Patient age, mo | Event | Serotype-specific IgG, µg/mL |
||||||
---|---|---|---|---|---|---|---|---|
4 | 6B | 9V | 14 | 18C | 19F | 23F | ||
1.9 | PCV7 dose 1 | |||||||
3.9 | PCV7 dose 2 | |||||||
13.4 | PCV7 dose 3 | |||||||
22.8 | Cochlear implant | |||||||
23.4 | Pneumococcal meningitis (episode 1) | |||||||
24.4 | PCV7 dose 4 | |||||||
25.6 | Pneumococcal serologic testing | 0.12 | 27.6 | 23.0 | 36.9 | 13.8 | 57.0 | 41.1 |
27.8 | PPV23 dose 1 | |||||||
28.8 | Pneumococcal serologic testing | 0.18 | 14.2 | 13.1 | 30.4 | 11.4 | 11.7 | 32.0 |
32.0 | Pneumococcal meningitis (episode 2) | |||||||
35.1 | PCV7 dose 5 | |||||||
36.1 | Pneumococcal serologic testing | 0.20 | 18.40 | 7.12 | 12.50 | 12.40 | 2.78 | 37.1 |
39.0 | PCR positive nasopharyngeal swab specimen for Streptococcus pneumoniae serotype 4 |
*PCV7, 7-valent pneumococcal conjugate vaccine; PPV23, 23-valent pneumococcal polysaccharide vaccine. Blank spaces indicate not tested.
Page created: May 11, 2012
Page updated: May 11, 2012
Page reviewed: May 11, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.